• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Self-enzyme chemiluminescence immunoassay capable of rapidly diagnosing the infection of influenza A (H1N1) virus

tetano

Editor, Senior Moderator
Talanta. 2019 Jan 15;192:189-196. doi: 10.1016/j.talanta.2018.09.049. Epub 2018 Sep 15.
[h=1]Self-enzyme chemiluminescence immunoassay capable of rapidly diagnosing the infection of influenza A (H1N1) virus.[/h] Kyme H[SUP]1[/SUP], Lee CT[SUP]1[/SUP], Kim YT[SUP]2[/SUP], Lee JH[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] A highly sensitive self-enzyme immunoassay with 1,1'-oxalyldiimidazole chemiluminescence (ODI-CL) detection was developed for the first time to quantify influenza A (H1N1) virus. A specific capture antibody, capable of capturing hemagglutinin (HA) subtypes of H1N1, was immobilized on the surface of the magnetic Au-Fe[SUB]3[/SUB]O[SUB]4[/SUB] nanocomposite. Neuraminidase (NA) subtype of H1N1 was acts as an enzyme in the self-enzyme immunoassay. A sample mixed with HA antibodies immobilized on the surface of magnetic Au-Fe[SUB]3[/SUB]O[SUB]4[/SUB] nanocomposites was incubated for 1 h at 37 ?C. After the incubation, magnetic Au-Fe[SUB]3[/SUB]O[SUB]4[/SUB] nanocomposites separated with a magnetic bar were washed 3 times using phosphate buffered saline with Tween-20 (PBST). Then, 4-Methylumbelliferyl-N-acetyl-α-D-neuraminic acid (MUNANA), a fluorogenic substrate of NA, was added and incubated for 10 min to produce 4-Methylumbelliferone (4-MU) from the enzyme reaction between MUNANA and NA of H1N1. After the incubation, the solution containing 4-MU emitted bright light with the addition of ODI-CL reagents (e.g., H[SUB]2[/SUB]O[SUB]2[/SUB] and ODI). The relative CL intensity of 4-MU was proportionally enhanced with the increase of H1N1. Also, the brightness and color of 4-MU light emitted from the self-enzyme immunoassay was dependent on pH. The self-enzyme immunoassay was able to analyze trace levels of influenza A (H1N1) virus with good accuracy, precision, reproducibility and excellent selectivity. The limit of detection (LOD = 3σ/slope) was as low as 0.19 U/ml. We expect that the self-enzyme immunoassay can be applied as a cost-effective and rapid method capable of selectively quantifying a specific influenza A virus such as H1N1, H3N2, and H5N1.


[h=4]KEYWORDS:[/h] 1,1′-Oxalyldiimidazole (ODI); 4-Methylumbelliferyl-N-acetyl-α-D-neuraminic acid (MUNANA); Chemiluminescence; Enzyme immunoassay; Influenza A virus; Nanocomposites; Neuraminidase

PMID: 30348377 DOI: 10.1016/j.talanta.2018.09.049
 
Back
Top Bottom